Development of a CO2-bicarbonate combined membrane capture system for accessible treatment of acute respiratory failure
Ended Project Grant Awarded Last action
- Award ID
- R43HL158345
- Recipient
-
X-Cor Therapeutics Inc. UEI C8ALEDEUU658
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,172,470
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Funding
-
- $879,348.87 Federal
- $293,121.00 Non-federal
- Place of performance
- Framingham, MA 01702, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | -$14 | $0 | |
| Amendment | $293,121 | $0 | |
| Amendment | $293,121 | $0 | |
| Original award | $293,121 | $293,121 |
Quick answers
Who received award R43HL158345?
R43HL158345 was awarded to X-Cor Therapeutics Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on September 17, 2021.
How much is award R43HL158345 worth?
$1,172,470 has been obligated on R43HL158345: $879,349 in federal funding and $293,121 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award